NO941561L - Bifunksjonelle urokinasevarianter med forbedrede fibrinolytiske egenskaper og trombinhemmende virkning - Google Patents

Bifunksjonelle urokinasevarianter med forbedrede fibrinolytiske egenskaper og trombinhemmende virkning

Info

Publication number
NO941561L
NO941561L NO941561A NO941561A NO941561L NO 941561 L NO941561 L NO 941561L NO 941561 A NO941561 A NO 941561A NO 941561 A NO941561 A NO 941561A NO 941561 L NO941561 L NO 941561L
Authority
NO
Norway
Prior art keywords
inhibitory effect
thrombin inhibitory
bifunctional urokinase
fibrinolytic properties
improved fibrinolytic
Prior art date
Application number
NO941561A
Other languages
English (en)
Other versions
NO941561D0 (no
Inventor
Gerd J Steffens
Stephan Wnendt
Johannes Schneider
Regina Heinzel-Wieland
Derek John Saunders
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of NO941561D0 publication Critical patent/NO941561D0/no
Publication of NO941561L publication Critical patent/NO941561L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Bifunksjonelle urokinasevarianter med forbedrede fibrinolytiske egenskaper og trombinhemmende virkning, plasmider for anvendelse ved isolering av dette polypeptidet samt trombolytika og som virkestoff inneholder en bifunksjonell urokinasevariant, er beskrevet.
NO941561A 1993-07-15 1994-04-28 Bifunksjonelle urokinasevarianter med forbedrede fibrinolytiske egenskaper og trombinhemmende virkning NO941561L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4323754A DE4323754C1 (de) 1993-07-15 1993-07-15 Bifunktionelle Urokinasevarianten mit verbesserten fibrinolytischen Eigenschaften und thrombinhemmender Wirkung

Publications (2)

Publication Number Publication Date
NO941561D0 NO941561D0 (no) 1994-04-28
NO941561L true NO941561L (no) 1995-01-16

Family

ID=6492909

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941561A NO941561L (no) 1993-07-15 1994-04-28 Bifunksjonelle urokinasevarianter med forbedrede fibrinolytiske egenskaper og trombinhemmende virkning

Country Status (26)

Country Link
US (2) US5681721A (no)
EP (1) EP0669394B1 (no)
JP (1) JPH07143878A (no)
KR (1) KR960014346A (no)
CN (1) CN1057124C (no)
AT (1) ATE189261T1 (no)
AU (1) AU679512B2 (no)
CA (1) CA2127897A1 (no)
CZ (1) CZ288536B6 (no)
DE (2) DE4323754C1 (no)
DK (1) DK0669394T3 (no)
ES (1) ES2145075T3 (no)
FI (1) FI943354A7 (no)
GR (1) GR3032488T3 (no)
HR (1) HRP940366B1 (no)
HU (1) HU217101B (no)
IL (1) IL109107A0 (no)
NO (1) NO941561L (no)
NZ (1) NZ260991A (no)
PL (1) PL176971B1 (no)
PT (1) PT669394E (no)
RU (1) RU2143490C1 (no)
SI (1) SI0669394T1 (no)
SK (1) SK281586B6 (no)
UA (1) UA27132C2 (no)
ZA (1) ZA944202B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4440892A1 (de) * 1994-11-17 1996-05-23 Gruenenthal Gmbh Proteine mit fibrinolytischen und gerinnungshemmenden Eigenschaften
DE4442665A1 (de) * 1994-11-30 1996-06-05 Gruenenthal Gmbh Chimäre Proteine mit fibrinolytischen und thrombinhemmenden Eigenschaften
CN1057125C (zh) * 1996-04-26 2000-10-04 南京大学 五种尿激酶变体基因及在大肠杆菌中的表达
CN1111739C (zh) * 1997-02-04 2003-06-18 许文俊 凝血、纤溶功能动态测定试剂
WO1999037149A1 (en) * 1998-01-27 1999-07-29 Brigham & Women's Hospital Methods of treating cytotoxic damage
US7498310B1 (en) 1998-08-13 2009-03-03 Beiersdorf Ag Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin of age marks and/or for preventing tanning of the skin, in particular tanning of the skin caused by UV radiation
WO2001097752A2 (en) * 2000-06-20 2001-12-27 The Trustees Of The University Of Pennsylvania Compositions comprising urokinase for modulating muscle contractility and angiogenisis
US7361493B1 (en) 2004-05-26 2008-04-22 The United States Of America As Represented By The Secretary Of The Department Of Veterans Affairs Production of urokinase in a three-dimensional cell culture
PT1737889E (pt) 2004-10-19 2010-12-13 Lonza Ag Método para síntese de péptidos em fase sólida
CN104193807B (zh) * 2014-09-28 2016-06-15 广州贝奥吉因生物科技有限公司 凝血酶抑制多肽及其制备方法、应用
CN105385617A (zh) * 2015-09-23 2016-03-09 河北省科学院生物研究所 一株产纤溶酶的海洋放线菌株、用途以及由其制备的纤溶酶及纤溶酶的应用
CN110139871A (zh) 2016-12-16 2019-08-16 悉尼大学 用于治疗中风和相关凝血障碍的凝血酶抑制剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3930944A (en) * 1975-03-31 1976-01-06 Abbott Laboratories Urokinase production
DE3445517C2 (de) * 1984-12-13 1993-11-18 Ciba Geigy Für ein Hirudin-ähnliches Protein codierende DNA-Sequenz und Verfahren zur Herstellung eines Hirudin-ähnlichen Proteins
US4751180A (en) * 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US5002887A (en) * 1986-01-31 1991-03-26 Genetics Institute, Inc. Truncated thrombolytic proteins
US5188829A (en) * 1987-08-19 1993-02-23 Sagami Chemical Research Center Rapidly acting prourokinase
DE3804600A1 (de) * 1988-02-13 1989-08-24 Basf Ag Mischung aus einer thrombolytisch wirkenden und einer antithrombotischen substanz
GB8822147D0 (en) * 1988-09-21 1988-10-26 Ciba Geigy Ag Pharmaceutically active combination
US5256770A (en) * 1990-04-09 1993-10-26 Schering Ag Oxidation resistant thrombomodulin analogs
EP0482069A1 (en) * 1989-07-20 1992-04-29 Biogen, Inc. Combinations and methods for treating or preventing thrombotic diseases
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
US5328898A (en) * 1990-06-22 1994-07-12 Duke University Factor XIIIA fibrin binding fragments
GB9015369D0 (en) * 1990-07-12 1990-08-29 Erba Carlo Spa Amidated fibrinolytic enzymes and their precursors,and processes for their preparation
US5242810A (en) * 1990-12-07 1993-09-07 Biogen, Inc. Bifunctional inhibitors of thrombin and platelet activation
US5688768A (en) * 1991-02-19 1997-11-18 Cor Therapeutics, Inc. Recombinant thrombin receptor and related pharmaceuticals
AU1873092A (en) * 1991-04-09 1992-11-17 Brigham And Women's Hospital Chimeric molecule with plasminogen activator activity and affinity for atherosclerotic plaques
US5376367A (en) * 1991-11-22 1994-12-27 Immunex Corporation Fusion proteins comprising MGF and IL-3
US5571708A (en) * 1993-04-19 1996-11-05 Bristol-Myers Squibb Company Thrombin-activatable plasminogen activator
RU2061043C1 (ru) * 1993-11-16 1996-05-27 Научно-производственная фирма "Нарт" Способ повышения устойчивости урокиназы к нагреванию

Also Published As

Publication number Publication date
HK1010109A1 (en) 1999-06-11
RU94026095A (ru) 1997-03-10
AU6452594A (en) 1995-01-27
FI943354A0 (fi) 1994-07-14
HRP940366B1 (en) 2001-02-28
GR3032488T3 (en) 2000-05-31
CZ288536B6 (cs) 2001-07-11
ZA944202B (en) 1995-02-08
DK0669394T3 (da) 2000-05-29
FI943354L (fi) 1995-01-16
SI0669394T1 (en) 2000-04-30
EP0669394B1 (de) 2000-01-26
UA27132C2 (uk) 2000-02-28
SK281586B6 (sk) 2001-05-10
DE4323754C1 (de) 1994-12-01
HUT70579A (en) 1995-10-30
HU217101B (hu) 1999-11-29
ATE189261T1 (de) 2000-02-15
SK84594A3 (en) 1995-03-08
CZ170694A3 (en) 1995-02-15
NO941561D0 (no) 1994-04-28
HU9402063D0 (en) 1994-09-28
EP0669394A1 (de) 1995-08-30
DE59409104D1 (de) 2000-03-02
HRP940366A2 (en) 1997-04-30
JPH07143878A (ja) 1995-06-06
RU2143490C1 (ru) 1999-12-27
PL304290A1 (en) 1995-01-23
AU679512B2 (en) 1997-07-03
PL176971B1 (pl) 1999-08-31
PT669394E (pt) 2000-07-31
CN1057124C (zh) 2000-10-04
ES2145075T3 (es) 2000-07-01
NZ260991A (en) 1995-10-26
IL109107A0 (en) 1994-06-24
US5747291A (en) 1998-05-05
CA2127897A1 (en) 1995-01-16
FI943354A7 (fi) 1995-01-16
US5681721A (en) 1997-10-28
KR960014346A (ko) 1996-05-22
CN1102438A (zh) 1995-05-10

Similar Documents

Publication Publication Date Title
AU1061988A (en) Phosphinothricin-resistance gene active in plants, and its use
ES8801552A1 (es) Un procedimiento para preparar una proteina hibrida fibrinoliticamente activa.
FI960059L (fi) Proteaasiaktiivisuutta omaava entsyymi
NO912243L (no) Forbedrede polymer/polyol-blandinger som egner seg for anvendelse ved fremstilling av polyuretaner, og forhaandsformede stabilisatorsystemer for anvendelse ved fremstilling av polymer/polyol-blandingene.
MXPA06000247A (es) Tetrahidro-1h-pirazolo[3,4-c]piridinas sustituidas composiciones que las contienen y su utilizacion.
NO941561L (no) Bifunksjonelle urokinasevarianter med forbedrede fibrinolytiske egenskaper og trombinhemmende virkning
WO1996003515A3 (en) Surface expression of enzyme in gene directed prodrug therapy
MY114140A (en) Novel enzymes and prodrugs for use in antibody-directed enzyme prodrug therapy.
DK0385279T3 (da) Biologisk aktive midler samt præparater og materialer, der indeholder de biologisk aktive midler
DK68593D0 (da) Elektroaktive materialer, fremgangsmaade til deres fremstilling samt anvendelse heraf
ZA949151B (en) 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents.
ZA962133B (en) Cyclic urea HIV protease inhibitors.
BR9405606A (pt) Uso de amidoaminas em composições oftálmicas
EP0400219A3 (en) Use of creosote as an antispasmodic agent
ZA949874B (en) B3-adrenergic agents, benzodioxole dicarboxylates and their use in pharmaceutical compositions.
ES2152315T3 (es) Xamoneline tartrato.
AU4227189A (en) Cyclopeptide derivatives, usable as selective inhibitors of proteases with active serine
WO1998025650A3 (en) Multi-purpose compositions for cleaning and disinfecting of lenses
NO900088L (no) Fremgangsmaate ved bestemmelse av den fibrinolytiske totalaktivitet i plasma.
TR199802703T2 (xx) HIV tedavisinde Vx478, Zidov�din, ve/veya 1592U89 i�eren kombinasyonlar�n kullan�m�.
EP0038003A3 (en) Antidepressant pyrrolylpiperidines
AU4203789A (en) 1,4-dihydrothionapthoquinone and heterocyclic congeners which inhibit lipoxygenase enzymes
Bieniecki THE IMPULSE POWERS SOURCE IN CATHODIC PROTECTION INSTALLATIONS(Polish)
WO1991019793A3 (en) Hybrid plasminogen activators
Dixon Japanese lessons for the British builder

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application